Partially involuting congenital hemangioma is a rare blood vessel growth that is fully formed at birth. Many people first hear about partially involuting congenital hemangioma when a baby has a round or raised skin mark that looks dark pink, red, or purple. The early signs of partially involuting congenital hemangioma can include a warm lesion with tiny visible blood vessels, and it often shrinks some over time but does not fully go away. It is usually recognized in newborns and infants, and treatment may include watchful follow-up, medicines for pain or ulcer care, or sometimes surgery or other procedures if it causes problems. Most partially involuting congenital hemangioma is not life-threatening, but the outlook depends on its size and where it is located.
How many people live with Partially involuting congenital hemangioma?
Worldwide and U.S. prevalence estimates for partially involuting congenital hemangioma are not consistently reported by a single authoritative source. Because it is very rare and is usually described in small published case series rather than counted in large registries, there is no reliable current estimate for how many people are living with it worldwide or in the United States.
Overview
Partially involuting congenital hemangiomaSymptoms
Partially involuting congenital hemangioma is usually present at birth as a round, warm, raised skin mark that may look red-purple with pale areas and visible veins. It often shrinks somewhat in early childhood but does not fully go away.
Outlook and prognosis
Partially involuting congenital hemangioma is present at birth and usually shrinks only partway over time. Many living with partially involuting congenital hemangioma keep a smaller, lasting lump or skin change. Outlook is generally good, though some need treatment for pain, bleeding, or appearance.
Causes and risk factors
Partially involuting congenital hemangioma usually happens before birth from a random change in blood vessel cells. It is rarely inherited. No clear lifestyle, environmental, or pregnancy-related risk factors are known.
Genetic influences
Genetics seem to play a limited role in partially involuting congenital hemangioma. Most cases are not inherited and are thought to result from gene changes that happen by chance during early development, rather than from a parent’s DNA.
Diagnosis
Diagnosis of partially involuting congenital hemangioma is usually based on its appearance at birth and how it changes over time. Doctors may confirm it with an exam, ultrasound, or MRI to check blood flow and rule out similar growths.
Treatment and drugs
Partially involuting congenital hemangioma is often watched closely, since it usually shrinks only partway over time. Treatment may include wound care for skin breakdown, pain relief, or laser treatment. Surgery can help if it leaves bleeding, ulceration, or a bothersome lump.
Symptoms
Partially involuting congenital hemangioma is usually noticeable at birth as a well-formed red to purple spot or lump on the skin. For many people with partially involuting congenital hemangioma, the mark slowly shrinks during infancy and childhood but does not go away completely. The early features of partially involuting congenital hemangioma often include a warm, raised area with visible small blood vessels or a pale rim. Features can vary from person to person and can change over time.
This mark is usually fully formed when a baby is born, rather than appearing days or weeks later. Many living with partially involuting congenital hemangioma have a spot or lump that is obvious right away.
It often looks like a round or oval red, purple, or deep pink patch or lump. Small surface blood vessels and a lighter rim around the edge can make it stand out more.
The area may be raised and can feel warmer than the nearby skin because it contains many blood vessels. Some spots feel soft, while others feel firmer to the touch.
Partially involuting congenital hemangioma often becomes smaller or flatter over time, especially during infancy and early childhood. Even so, it usually does not disappear completely.
How people usually first notice Partially involuting congenital hemangioma?
The first signs of partially involuting congenital hemangioma are usually noticed at birth, because this type of birthmark is already fully formed rather than appearing weeks later. Families and doctors often first see a round or oval, raised red-purple skin lesion with tiny visible blood vessels, sometimes surrounded by a pale rim, and it may feel warmer than the nearby skin. How partially involuting congenital hemangioma is first noticed can vary with its size and location, but over time many living with it show only partial shrinking instead of the more complete fading seen in some other congenital hemangiomas.
Types of Partially involuting congenital hemangioma
No distinct types of Partially involuting congenital hemangioma are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can delay the onset of a partially involuting congenital hemangioma, because this kind of blood vessel birthmark is already fully formed at birth. Diet, exercise, sleep, or supplements have not been shown to prevent it or slow its appearance, but early care from a doctor who knows vascular birthmarks can help watch for problems like bleeding, pain, or skin breakdown and decide whether treatment is needed. While you cannot prevent when it starts, careful follow-up can still help many people living with it stay as healthy and comfortable as possible.
What genetics can tell you about symptoms
For people with partially involuting congenital hemangioma, genetics can sometimes show changes in genes involved in blood vessel growth, but these findings do not yet let doctors reliably predict exactly which symptoms will happen, how large the birthmark will be, or how much it will shrink over time. The main pattern is still based on what is seen in real life: these growths are usually already fully formed at birth, and many living with this condition have a lump or raised area that only partly gets smaller during infancy and early childhood. In other words, genetics may help confirm that this is part of a blood vessel growth disorder, but it is not usually used to forecast day-to-day symptoms or timing in a precise way.
Causes and risk factors
The exact causes of partially involuting congenital hemangioma are still being studied, but it usually begins before birth when a group of blood vessels grows in an unusual way. This is often linked to a gene change in the affected tissue, such as GNAQ or GNA11. That change is usually new and is not inherited from a parent. Family history is uncommon, and no clear lifestyle or environmental exposure during pregnancy has been proven to cause partially involuting congenital hemangioma. Researchers are still learning how these pieces fit together.
What are the most common causes or risk factors?
Partially involuting congenital hemangiomas usually happen by chance while a baby is developing before birth, when a patch of blood vessels forms in an unusual way. They are usually not inherited, and in some cases doctors think small gene changes happen only in the hemangioma itself, rather than being passed down through the family. No clear everyday risk factors, such as anything a parent did during pregnancy, have been strongly proven for this condition.
Environmental and biological risk factors
When people look for risk factors for partially involuting congenital hemangioma, the main point is that few have been clearly proven. Most cases seem to arise sporadically while blood vessels are forming before birth. Researchers are still exploring how outside influences interact with our inner biology. So far, no single maternal illness, exposure, or birth event reliably predicts this condition.
No medication, infection, chemical, or other outside exposure has been firmly shown to cause partially involuting congenital hemangioma. In many pregnancies, there is no clear event that explains why it developed.
Older maternal age, multiple pregnancy, and common maternal health conditions have not been clearly tied to partially involuting congenital hemangioma. Doctors usually cannot identify a specific pregnancy-related biological trigger.
Being born early or at a low birth weight is a known risk pattern for infantile hemangiomas, but it has not been clearly linked to congenital hemangiomas such as PICH. This distinction helps explain why the risk profile is different.
The strongest biological explanation is an early developmental change in a small area of blood vessels before birth. This appears to be a sporadic event rather than something parents could have predicted or prevented.
Genetic risk factors
Most partially involuting congenital hemangioma cases seem to start from a gene change that happens by chance in blood-vessel tissue very early in development. The change is usually limited to the hemangioma itself, rather than being present in every cell of the body. When people ask about the genetic causes of partially involuting congenital hemangioma, the clearest finding so far is a tissue-limited change in genes such as GNAQ or GNA11, which help control blood-vessel growth signals. An inherited tendency is not usually seen.
GNAQ or GNA11: Some partially involuting congenital hemangiomas carry changes in GNAQ or GNA11, genes that help blood-vessel cells send growth signals. When one of these changes happens in the right cells at the right time, the hemangioma can form before birth.
Chance mutation: The main genetic event usually happens by chance after conception, not because a parent passed it down. This is why most people with partially involuting congenital hemangioma do not have a family history of it.
Mosaic pattern: The gene change is often found only in the hemangioma tissue and not in the rest of the body. This localized pattern, known as mosaicism, helps explain why the growth affects one area rather than the whole body.
Family history: A strong inherited risk for partially involuting congenital hemangioma has not been established. For most families, the chance of having another child with the same condition is thought to be low, although unusual histories may still warrant genetics advice.
Lifestyle risk factors
Lifestyle habits do not cause a partially involuting congenital hemangioma, but they can influence irritation, skin breakdown, bleeding, pain, and healing over time. In practice, how lifestyle affects partially involuting congenital hemangioma depends largely on protecting the lesion and reducing triggers that worsen local symptoms. The most relevant factors are day-to-day skin care, friction, heat exposure, smoking, and activities that increase trauma to the area.
Dry, fragile, or poorly protected skin over the hemangioma is more likely to crack, ulcerate, or bleed. Gentle cleansing, regular moisturizing, and prompt care of small breaks in the skin can lower these risks.
Tight clothing, rubbing straps, shaving over the area, or repeated bumps can irritate the lesion and trigger pain or bleeding. Choosing soft fabrics and avoiding repeated pressure is one of the most important lifestyle risk factors for partially involuting congenital hemangioma.
Hot baths, saunas, and overheating can increase local blood flow and make the hemangioma look darker, feel fuller, or become more uncomfortable. Keeping the area cool may help limit swelling and tenderness.
Contact sports or activities with frequent impact can raise the chance of bruising and bleeding, especially if the hemangioma is exposed or prominent. Safer modifications are often more useful than avoiding exercise completely.
Risk prevention
Because partially involuting congenital hemangioma is present at birth, there is no proven way to prevent the growth itself from forming. Prevention for partially involuting congenital hemangioma is mainly about lowering the chance of bleeding, skin breakdown, pain, and other complications as a child grows. Different people need different prevention strategies—there’s no single formula. Care is often tailored to the size, location, and how quickly the area is changing.
Gentle skin care can help lower the risk of rubbing, cracking, and ulceration over a partially involuting congenital hemangioma. Soft clothing, mild cleansers, and avoiding friction from straps or rough fabrics often help protect the area.
Bumps and scrapes can make these lesions bleed more easily, especially if they sit on the scalp, face, arms, or legs. Padding the area when practical and being extra careful during sports or rough play may reduce injury.
Regular follow-up with the child’s doctor or vascular anomalies specialist can catch changes before they become bigger problems. Photos taken over time may help track growth, color change, pain, or new swelling at home.
Many living with partially involuting congenital hemangioma benefit from knowing basic first aid before an injury happens. If bleeding starts, steady direct pressure with a clean cloth for several minutes is usually the first step, and urgent care is needed if it does not stop.
Can you prevent Partially involuting congenital hemangioma?
No, there is no known way to prevent a partially involuting congenital hemangioma, which is a type of blood vessel birthmark that is already fully formed at birth. It develops before birth, and the exact cause is still not clear, so there are no proven steps during pregnancy or before conception that can reliably stop it from happening. Nothing clearly shows that a parent did or did not do caused it.
Transmission
Partially involuting congenital hemangioma is present at birth, but it is not an infection and cannot be caught from someone else through touch, blood, or the air. For many families, the main question is how partially involuting congenital hemangioma is inherited: in most cases, it is not passed from parent to child and seems to happen because of a new genetic change in cells that form blood vessels early in pregnancy. This means the chance of having another child with the same condition is usually low, although a genetics specialist may be helpful if there is an unusual family pattern or any doubt about the diagnosis.
When to test your genes
For partially involuting congenital hemangioma, genetic testing is not usually needed for early detection or routine care because diagnosis is typically made from the birth history, exam, and imaging. Testing may be considered if the lesion looks unusual, multiple birth differences are present, or your care team suspects a broader genetic condition.
Diagnosis
Partially involuting congenital hemangioma is usually recognized soon after birth because the mark is already fully formed, rather than appearing and growing over the first weeks of life. Many living with this condition have a round or oval vascular birthmark that may look purple, red, or bluish, sometimes with pale skin around it and visible surface veins. Doctors usually begin with the appearance of the lesion, how it has changed over time, and whether it has started to shrink, since these clues are central to the diagnosis of partially involuting congenital hemangioma.
Doctors ask whether the lesion was fully present at birth, because that strongly supports a congenital hemangioma rather than the more common infantile type. They also ask how the spot has changed over months and years, since partial shrinking is a key clue.
A careful exam looks at the size, shape, color, warmth, and texture of the lesion. The doctor also checks for features often seen in this condition, such as a firm vascular mass, small visible veins, or a pale rim around the edge.
The pattern over time helps separate partially involuting congenital hemangioma from other birthmarks and vascular tumors. These lesions are usually largest at birth and then shrink somewhat, but they do not disappear completely.
Ultrasound can show that the lesion has increased blood flow and can help define its depth. Doppler imaging also helps doctors tell it apart from cysts, malformations, or other soft tissue masses.
How is Partially involuting congenital hemangioma diagnosed?
Partially involuting congenital hemangioma is usually diagnosed by a specialist who looks at the mark, asks whether it was fully formed at birth, and follows how it changes over time, especially whether it shrinks some but does not go away completely. If the diagnosis is not clear, imaging tests such as an ultrasound or MRI scan can help show how deep it goes and how blood is flowing through it. A small tissue sample is only rarely needed, and genetic testing is not usually part of the diagnosis.
Stages of Partially involuting congenital hemangioma
Partially involuting congenital hemangioma often changes in a fairly predictable way over time, although the speed and extent of change can vary. These birthmarks are usually already fully formed at birth, so the pattern is less about new growth and more about what happens afterward. For many, the first step comes when usual activities start to feel different, such as a raised skin lump rubbing on clothing or drawing attention during diaper changes. Doctors usually start with a conversation about when the mark was first seen, how it has changed, and whether there has been pain, bleeding, or skin breakdown.
At birth
The hemangioma is usually fully present at birth rather than appearing weeks later. It may look like a round or oval raised area with a pink, purple, or bluish color and visible surface blood vessels.
Early infancy
In the first months of life, the mark usually does not keep rapidly enlarging the way some other infant birthmarks do. This timing can help doctors when they assess early symptoms of partially involuting congenital hemangioma.
Partial shrinking
Over time, often during infancy or early childhood, part of the hemangioma becomes smaller, flatter, or less brightly colored. Sometimes answers come quickly, while other times it takes longer.
Residual phase
After the early improvement, a remaining portion usually stays in place instead of disappearing completely. Many living with partially involuting congenital hemangioma have a lasting patch, fullness, or stretched skin that changes little after that.
Outlook and prognosis
The outlook for partially involuting congenital hemangioma is generally good, because these lesions are benign and often shrink to some degree over time, especially during early childhood. However, unlike rapidly involuting congenital hemangiomas, they usually do not disappear completely and may leave behind a persistent mass, skin changes, or cosmetic asymmetry. Most children have a normal life expectancy, and mortality from a partially involuting congenital hemangioma is exceedingly rare. Prognosis depends mainly on the size and location of the lesion, since tumors near vital structures or those complicated by ulceration, bleeding, or high-output cardiac effects can require closer monitoring or treatment. When intervention is needed, outcomes are often favorable with management tailored to symptoms, appearance, and function.
Long-term effects
Many living with partially involuting congenital hemangioma see the birthmark shrink only partway, then remain as a stable skin change for years. The long-term picture is often a leftover patch, lump, or area of altered skin rather than ongoing growth. In some children and adults, the area can still affect appearance, comfort, or nearby tissues depending on its size and location.
A partially involuting congenital hemangioma often leaves a lasting mark on the skin after the early shrinking phase slows down. This may look like a flat patch, a raised area, extra loose skin, or visible small blood vessels.
Some people are left with a soft tissue lump or fullness where the lesion was thicker at birth. For many, this can mean a lasting contour difference that is more noticeable on the face, limbs, or trunk.
The skin may stay pink, red, purple, or slightly darker than the surrounding area over the long term. These color changes can remain even when the hemangioma becomes smaller.
The affected skin can feel thinner, thicker, scar-like, or less even than nearby skin. Over time, daily routines may include noticing the area catches on clothing more easily or looks different as the body grows.
How is it to live with Partially involuting congenital hemangioma?
Living with a partially involuting congenital hemangioma often means growing up with a birthmark or soft tissue lump that is already present at birth and then shrinks only partway over time, so its effect on daily life depends a lot on its size and where it sits on the body. Many people have little physical limitation, while others may deal with tenderness, skin breakdown, bleeding, cosmetic difference, or trouble with movement, vision, feeding, or clothing if the hemangioma is large or in a sensitive area.
For families, this can mean regular checkups, watching for changes, and sometimes decisions about wound care, laser treatment, or surgery if the lesion causes symptoms or remains very noticeable. The social side matters too: comments, staring, and worries about appearance can affect confidence, and people around them may need to offer patience, practical support, and reassurance rather than alarm.
Treatment and drugs
Partially involuting congenital hemangioma is usually managed based on how much it affects comfort, appearance, bleeding risk, or nearby body functions, because these birthmarks often shrink partly over time but do not always go away completely. In many living with partially involuting congenital hemangioma, treatment may simply mean regular follow-up visits and photos to track changes, especially if the area is stable and not causing problems. If it ulcerates, bleeds, causes pain, or interferes with vision, breathing, feeding, or movement, care may include wound care, pain relief, or a procedure to remove or reduce the lesion. Doctors sometimes recommend a combination of lifestyle changes and drugs, but unlike common infantile hemangiomas, these lesions usually do not respond as well to medicines such as propranolol, so surgery or other specialist procedures may be more helpful in selected cases. Treatment often looks different for each person, and a vascular anomalies specialist can help decide whether watchful waiting or active treatment is the best approach.
Can you cure Partially involuting congenital hemangioma?
There is no medicine that can fully cure a partially involuting congenital hemangioma, which is a blood vessel growth present at birth. Many living with this condition will see it shrink on its own over time, but it often does not go away completely. If it causes bleeding, pain, skin problems, or distress about how it looks, doctors may recommend monitoring, surgery, or sometimes laser treatment to manage problems and improve comfort.
Non-drug treatment
Partially involuting congenital hemangioma is often managed with careful monitoring rather than immediate treatment, especially if it is shrinking on its own and not causing problems. For many families, this can mean regular checkups, photos over time, and simple skin care at home. Not every approach works the same way, because treatment depends on the hemangioma’s size, location, and whether it causes pain, bleeding, or trouble with movement or daily activities.
Many living with partially involuting congenital hemangioma do well with observation alone. Doctors may track changes in size, color, firmness, and any new symptoms over months or years.
Follow-up visits help check whether the area is shrinking as expected or leaving behind extra skin, scar-like tissue, or visible blood vessels. This is especially helpful when watching for early symptoms of partially involuting congenital hemangioma problems, such as ulceration, repeated bleeding, or interference with vision or feeding.
Gentle skin care can help protect the surface if the hemangioma rubs on clothing or becomes fragile. If the skin breaks down, careful wound care and non-stick dressings may lower discomfort and reduce the chance of infection.
In some cases, a specialist may suggest compression garments or wraps, especially for larger hemangiomas on an arm, leg, or trunk. These can sometimes reduce swelling, protect the area, and make daily movement more comfortable.
Your genes may have an impact on how drugs work for you
For people living with partially involuting congenital hemangioma, medicines are not usually the main treatment, and these birthmarks often do not shrink much with drugs that are commonly used for other kinds of hemangiomas. At this point, there is no well-established evidence that everyday genetic differences clearly predict which medicine will help, so genetic testing is not a routine part of treatment for this condition. In day-to-day care, doctors usually focus more on the hemangioma’s size, location, bleeding, pain, or skin breakdown when deciding whether careful watch, a procedure, or surgery is the best next step.
Pharmacological treatments
For partially involuting congenital hemangioma, there is no medicine proven to make the tumor reliably shrink, so treatment is often watchful waiting unless it causes symptoms. Drugs are mainly used to help with problems around the lesion, such as pain, skin breakdown, bleeding risk, or infection. Not everyone responds to the same medication in the same way, and some drugs that work for infantile hemangiomas usually do not help this condition. When families ask about medication for partially involuting congenital hemangioma, the answer is often supportive treatment rather than a drug that targets the growth itself.
Propranolol is a common hemangioma drug, but partially involuting congenital hemangioma usually does not respond the way infantile hemangiomas do. Because of that, it is not considered routine treatment, though a specialist may occasionally discuss it when the diagnosis is still being sorted out.
Acetaminophen and ibuprofen may be used if the area is sore, tender, or uncomfortable from stretching or minor trauma. For many, this can mean easier sleep, less fussing in infants, or less pain with clothing and movement.
Mupirocin or similar antibiotic ointments may be used if the skin over the hemangioma breaks down and there is concern for a surface infection. These medicines help treat bacteria in the wound, but they do not shrink the hemangioma itself.
Drugs such as cephalexin may be prescribed if there are clearer signs of infection, like spreading redness, warmth, pus, or fever. The goal is to treat the infection promptly while the hemangioma and skin heal.
Genetic influences
Many living with partially involuting congenital hemangioma wonder whether it started because of something inherited. In most cases, the gene change happens only in the hemangioma itself while a baby is developing, rather than being passed down through a family. A change in a gene can sometimes affect health, and in this condition, researchers have found changes in genes such as GNAQ or GNA11 that help control blood vessel growth. That means the genetic causes of partially involuting congenital hemangioma are usually somatic, or limited to the affected tissue, not a whole-body inherited condition. For families, this usually means the chance of having another child with the same condition is low, although a specialist may suggest more evaluation if the diagnosis is uncertain or other unusual findings are present.
Is Partially involuting congenital hemangioma genetic?
Genetics seem to play a limited role in partially involuting congenital hemangioma. Most cases are not inherited and are thought to result from gene changes that happen by chance during early development, rather than from a parent’s DNA.
Having a genetic risk is not necessarily a diagnosis
Gene variants are a normal part of human biology and are widespread in the general population. Most do not have a direct impact on health and simply reflect the natural differences seen among people. For many genes, having a variant connected with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a part. In some situations, though, a single well-understood variant in a particular gene can be enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with partially involuting congenital hemangioma, treatment decisions are usually shaped more by where the growth is, whether it is causing pain, bleeding, skin breakdown, or strain on nearby tissues, than by a routine genetic test. Researchers have found that congenital hemangiomas can carry changes in genes inside the lesion itself, which helps explain why partially involuting congenital hemangioma behaves differently from the more common infantile hemangioma. Not every difference in response is genetic, but these biologic differences are one reason medicines that often help infantile hemangiomas, such as propranolol, usually do not work as well for partially involuting congenital hemangioma. Because of that, care often centers on watchful follow-up, wound care if the skin is irritated, and sometimes a procedure or surgery if the hemangioma is causing ongoing problems. At this point, there is no widely used pharmacogenetic test that can reliably tell doctors which drug will work best for partially involuting congenital hemangioma. If you are wondering about the best treatment for partially involuting congenital hemangioma, it often helps to ask whether the plan is based on the lesion’s size, location, and symptoms rather than expecting a strong response to standard hemangioma medicine.
Interactions with other conditions
Partially involuting congenital hemangioma usually does not have strong links with other diseases, and for many people it is a single vascular growth rather than part of a broader illness. The main medical concern is that a large lesion can sometimes affect the body around it, such as causing skin breakdown, bleeding, pain, or in rare cases putting extra strain on the heart because blood flows through it so quickly. Another important aspect is how it may link with other diseases: it can be mistaken for other vascular conditions, including infantile hemangioma or a vascular malformation, so getting the diagnosis right matters for treatment and follow-up. In some babies, blood tests may briefly show low platelets or changes in clotting, but this is usually different from the more severe clotting problem seen with a rare tumor called Kasabach-Merritt phenomenon. If a partially involuting congenital hemangioma sits near the eye, airway, or liver, doctors may also watch for problems related to that area rather than from the tumor itself. Because early symptoms of partially involuting congenital hemangioma can overlap with other birthmarks or vascular growths, care is often safest when a pediatrician, dermatologist, and vascular anomalies team look at the full picture together.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Partially involuting congenital hemangioma?
Other birthmark-like growths made of extra blood vessels can look very similar, especially infantile hemangioma, other congenital hemangiomas that either shrink quickly or do not shrink, and blood vessel malformations such as venous or arteriovenous malformations. Doctors usually tell them apart by whether the spot was fully present at birth, how it changes over time, and whether it feels warm, raised, painful, or bleeds.
History
Partially involuting congenital hemangioma has likely existed for as long as babies have been born with visible birthmarks, but doctors only began separating it from other vascular birthmarks in the late 20th century. Unlike the more common infantile hemangioma, which usually appears after birth and then grows, this type is already fully formed at birth. That difference matters in real life: parents and clinicians may notice a firm, round, reddish or purple mark on day one, rather than something that develops over the first weeks.
Initially understood only through symptoms, later doctors recognized that congenital hemangiomas were a distinct group of blood vessel growths present from birth. As medical imaging, pathology, and long-term follow-up improved, specialists saw that not all congenital hemangiomas behaved the same way over time. Some shrank quickly, some stayed about the same, and some only partly faded. This led to the modern description of partially involuting congenital hemangioma, or PICH, for lesions that get smaller after birth but do not disappear completely.
That change in understanding helped families get clearer answers. In the past, a newborn with one of these marks might simply have been told they had a hemangioma, without much sense of what would happen next. Over time, doctors learned that the early symptoms of partially involuting congenital hemangioma and its course can differ from those of other birthmarks, which made follow-up more accurate and treatment decisions more tailored.
Today, partially involuting congenital hemangioma is recognized as part of a spectrum of congenital hemangiomas rather than a one-size-fits-all diagnosis. Researchers later identified a genetic basis for some vascular tumors in general, but the main advance for people living with PICH has been better classification and better prediction of how the lesion may change with age. For many families, that means more realistic counseling in infancy and fewer surprises as a child grows.